Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

Caryn Hughes, Graeme Clemens, Matthew J. Baker

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

LanguageEnglish
Pages429-430
Number of pages2
JournalTrends in Biotechnology
Volume33
Issue number8
Early online date10 Apr 2015
DOIs
Publication statusPublished - 17 Jul 2015

Fingerprint

Preclinical Drug Evaluations
Labels
Microscopic examination
Screening
Throughput
Infrared radiation
Pharmaceutical Preparations
Microscopy
Technology

Keywords

  • cancer
  • infrared
  • spectroscopy
  • high throughput
  • preclinical screening
  • biomarker

Cite this

@article{89a272f6fe8840ce94e733c1759c911c,
title = "Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy",
abstract = "High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.",
keywords = "cancer, infrared, spectroscopy, high throughput, preclinical screening, biomarker",
author = "Caryn Hughes and Graeme Clemens and Baker, {Matthew J.}",
year = "2015",
month = "7",
day = "17",
doi = "10.1016/j.tibtech.2015.03.010",
language = "English",
volume = "33",
pages = "429--430",
journal = "Trends in Biotechnology",
issn = "0167-7799",
number = "8",

}

Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy. / Hughes, Caryn; Clemens, Graeme; Baker, Matthew J.

In: Trends in Biotechnology, Vol. 33, No. 8, 17.07.2015, p. 429-430.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy

AU - Hughes, Caryn

AU - Clemens, Graeme

AU - Baker, Matthew J.

PY - 2015/7/17

Y1 - 2015/7/17

N2 - High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

AB - High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.

KW - cancer

KW - infrared

KW - spectroscopy

KW - high throughput

KW - preclinical screening

KW - biomarker

UR - http://www.scopus.com/inward/record.url?scp=84926660775&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2015.03.010

DO - 10.1016/j.tibtech.2015.03.010

M3 - Article

VL - 33

SP - 429

EP - 430

JO - Trends in Biotechnology

T2 - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 8

ER -